Celularity Inc. (CELU) vs eXoZymes, Inc. (EXOZ)

A side-by-side comparison of Celularity Inc. and eXoZymes, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

CELU

Celularity Inc.

$45M

$1.57HealthcareDelayed quote: Oct 6, 2026, 3:45 PM EDT

EXOZ

eXoZymes, Inc.

$52M

$5.55HealthcareDelayed quote: Oct 6, 2026, 2:58 PM EDT

Total return — CELU vs EXOZ

growth of $100 · dividends reinvested · last 2y

CELU -51.8% (-30.6%/yr)EXOZ -36.2% (-20.1%/yr)EXOZ compounded faster over this window

CELU EXOZ

CELU vs EXOZ: by the numbers

•EXOZ is the larger company ($52M vs $45M market cap).
•Both run net losses; EXOZ's is the smaller (0.00% vs -375.77% net margin).

Metrics side by side

Valuation

Metric	CELU	EXOZ
P/S ratio	2.39	N/A
P/B ratio	N/A	14.10

Profitability

Metric	CELU	EXOZ
Gross margin	79.62%	0.00%
Operating margin	-230.92%	0.00%
Net margin	-375.77%	0.00%
ROE	N/A	-278.89%
ROIC	-192.99%	-157.40%

Growth (annualized)

Metric	CELU	EXOZ
Revenue CAGR (5Y)	8.31%	N/A
Total return CAGR (5Y)	-52.57%	N/A

Go deeper

Full CELU analysis Full EXOZ analysis Interactive comparison tool

Dig into the metrics

Celularity ROE eXoZymes ROE Celularity operating margin eXoZymes operating margin Celularity revenue growth eXoZymes revenue growth Celularity free cash flow eXoZymes free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.